MYD88 and neoplasm: They found a large-sized and non-dividing CD44+ ALDH1+MYD88+ subtype of OCs, which exhibits several properties of CSCs, including the capacity to generate tumors in immunodeficient mice, the capacity of functioning as tumor vascular progenitors, and chemoresistance [30].